How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements

– Research article – Open Access – [Published:] How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements 967 (2021) [Cite this article](#citeas) 6 Accesses – Abstract Background New drugs including cancer drugs and orphan drugs are becoming increasingly more expensive. Risk sharing arrangements (RSAs) could manage the risk based on both financial impact and the health outcome of new drugs if reimbursed.

Read the source article at BMC Health Services Research
2021-09-14 01:00:00